TYPE: Prescription
BRAND: Ridate Once a Week
ACTIVE INGREDIENT: Risedronate Sodium
STRENGTH, PACK SIZE & GMS CODE:
35mg film-coated tablets x 4 ~ 44290
INDICATION:
Treatment of postmenopausal osteoporosis, to reduce the risk of vertebral fractures.
Treatment of established postmenopausal osteoporosis, to reduce the risk of hip fractures.
Treatment of osteoporosis in men at high risk of fractures.
Download Ridate 35mg SPC and Patient Information Leaflet here
